Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Payne

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|October 14, 2021
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISEHeather Payne, Angus Robinson, Bernard Rappe, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2020
Effect of <sup>18</sup>F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON TrialAndrew F Scarsbrook, David Bottomley, Eugene J Teoh, et al.
European Urology|August 31, 2024
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 1, 2022
Inconsistent language lateralisation - Testing the dissociable language laterality hypothesis using behaviour and lateralised cerebral blood flow, Adam J Parker, Zoe V J Woodhead, et al.
The Lancet. Oncology|March 13, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trialDavid Dearnaley, Victoria Hinder, Adham Hijab, et al.
Lancet (London, England)|June 16, 2009
Professionals Against Child Abuse express support for David SouthallDamian Armstrong, John Bridson, Margaret Crawford, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|October 14, 2021
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISEHeather Payne, Angus Robinson, Bernard Rappe, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2020
Effect of <sup>18</sup>F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON TrialAndrew F Scarsbrook, David Bottomley, Eugene J Teoh, et al.
European Urology|August 31, 2024
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|July 1, 2022
Inconsistent language lateralisation - Testing the dissociable language laterality hypothesis using behaviour and lateralised cerebral blood flow, Adam J Parker, Zoe V J Woodhead, et al.
The Lancet. Oncology|March 13, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trialDavid Dearnaley, Victoria Hinder, Adham Hijab, et al.
Lancet (London, England)|June 16, 2009
Professionals Against Child Abuse express support for David SouthallDamian Armstrong, John Bridson, Margaret Crawford, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|April 4, 2022
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After RadiotherapyTaimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
Pageof 12